Here’s everything you need to know.
MastCURe, a high-profile research consortium, has been awarded EUR1.3M in funding from the Eureka Eurostars program. The collaboration comprising Allegria Therapeutics, Cube Biotech, and the ...
Abstract: Multiple Instance Learning (MIL) has demonstrated promise in Whole Slide Image (WSI) classification. However, a major challenge persists due to the high computational cost associated with ...
The FDA is set to review 12 peptides after reversing their high-risk classification, marking a shift toward regulated access ...
Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong enrollment velocity and significant unmet medical need ...
New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...
The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century but ...
Drug-induced gingival overgrowth (DIGO) as an interdisciplinary clinical challenge, faces dual therapeutic barriers due to its unclear pathogenesis and high recurrence rate, forcing clinicians to ...
Abstract: Hyperspectral image (HSI) classification is an important issue in remote sensing field with extensive applications in Earth science. In recent years, a large number of deep learning-based ...
How do medicines work? In this prestigious and flexible BSc programme you’ll explore the science of drug action – from molecular interactions and cellular mechanisms through system and whole-body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results